José M. Cabral, MD

Article Type

Article

Changed

Thu, 11/15/2018 - 08:38

Display Headline

Amiodarone induced thyrotoxicosis: Diagnostic and therapeutic strategies

Author(s)

Gustavo A. Cardenas, MD

José M. Cabral, MD

Camilo A. Leslie, MD, MBA

Article PDF

content_70_624.pdf

Author and Disclosure Information

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Issue

Cleveland Clinic Journal of Medicine - 70(7)

Publications

Cleveland Clinic Journal of Medicine

Topics

Cardiology

Drug Therapy

Endocrinology

Page Number

624-626, 628-631

Read more about Amiodarone induced thyrotoxicosis: Diagnostic and therapeutic strategies

Sections

Reviews

Author(s)

Gustavo A. Cardenas, MD

José M. Cabral, MD

Camilo A. Leslie, MD, MBA

Author(s)

Gustavo A. Cardenas, MD

José M. Cabral, MD

Camilo A. Leslie, MD, MBA

Author and Disclosure Information

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF

content_70_624.pdf

Article PDF

content_70_624.pdf

Issue

Cleveland Clinic Journal of Medicine - 70(7)

Issue

Cleveland Clinic Journal of Medicine - 70(7)

Page Number

624-626, 628-631

Page Number